|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's range||511.19 - 515.09|
|52-week range||392.40 - 549.52|
|Beta (5Y monthly)||0.94|
|PE ratio (TTM)||20.19|
|Earnings date||24 Jan 2023 - 30 Jan 2023|
|Forward dividend & yield||5.12 (1.00%)|
|Ex-dividend date||02 Dec 2022|
|1y target est||566.29|
UnitedHealth (UNH) expects the top line to be within the range of $357-$360 billion in 2023.
Elevance Health (ELV) continues to benefit from sustained top-line growth, higher membership in Government business and a sturdy financial position.
ELV vs. PGNY: Which Stock Is the Better Value Option?